Загрузка...
Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
The pharmaceutical industry’s development of therapeutic medications for the treatment of Parkinson’s disease (PD) endures, as a result of the continuing need for better agents, and the increased clinical demand due to the aging population. Each new drug offers advantages and disadvantages to patien...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3763661/ https://ncbi.nlm.nih.gov/pubmed/24281662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph5060553 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|